Crescent Capital BDC, Inc. (NASDAQ:CCAP) Shares Sold by Mariner LLC

Mariner LLC decreased its holdings in Crescent Capital BDC, Inc. (NASDAQ:CCAP - Free Report) by 22.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 487,571 shares of the company's stock after selling 144,061 shares during the period. Mariner LLC owned about 1.32% of Crescent Capital BDC worth $9,371,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently bought and sold shares of CCAP. Ieq Capital LLC grew its stake in shares of Crescent Capital BDC by 2.6% during the fourth quarter. Ieq Capital LLC now owns 22,725 shares of the company's stock worth $437,000 after purchasing an additional 584 shares in the last quarter. Confluence Investment Management LLC boosted its holdings in shares of Crescent Capital BDC by 0.9% in the 4th quarter. Confluence Investment Management LLC now owns 73,839 shares of the company's stock valued at $1,419,000 after buying an additional 633 shares in the last quarter. Denali Advisors LLC grew its position in shares of Crescent Capital BDC by 0.5% in the 4th quarter. Denali Advisors LLC now owns 183,783 shares of the company's stock valued at $3,532,000 after buying an additional 855 shares during the last quarter. Van ECK Associates Corp raised its stake in Crescent Capital BDC by 2.3% during the 4th quarter. Van ECK Associates Corp now owns 45,562 shares of the company's stock worth $876,000 after acquiring an additional 1,006 shares in the last quarter. Finally, Wells Fargo & Company MN lifted its position in Crescent Capital BDC by 0.5% in the fourth quarter. Wells Fargo & Company MN now owns 253,182 shares of the company's stock valued at $4,866,000 after acquiring an additional 1,210 shares during the last quarter. Hedge funds and other institutional investors own 49.46% of the company's stock.

Crescent Capital BDC Trading Up 2.7 %

Shares of NASDAQ:CCAP traded up $0.42 during trading on Thursday, reaching $16.00. The stock had a trading volume of 50,166 shares, compared to its average volume of 143,413. Crescent Capital BDC, Inc. has a fifty-two week low of $13.54 and a fifty-two week high of $20.19. The business has a fifty day moving average price of $16.95 and a 200-day moving average price of $18.35. The stock has a market cap of $592.99 million, a P/E ratio of 8.04 and a beta of 0.56. The company has a quick ratio of 1.26, a current ratio of 1.32 and a debt-to-equity ratio of 1.18.

Crescent Capital BDC (NASDAQ:CCAP - Get Free Report) last posted its quarterly earnings data on Wednesday, February 19th. The company reported $0.55 EPS for the quarter, missing analysts' consensus estimates of $0.56 by ($0.01). The company had revenue of $46.40 million for the quarter, compared to analyst estimates of $47.27 million. Crescent Capital BDC had a net margin of 37.32% and a return on equity of 11.90%. As a group, analysts anticipate that Crescent Capital BDC, Inc. will post 2.09 earnings per share for the current fiscal year.

Crescent Capital BDC Announces Dividend

The company also recently disclosed a dividend, which was paid on Friday, March 14th. Shareholders of record on Friday, February 28th were given a $0.05 dividend. The ex-dividend date of this dividend was Friday, February 28th. Crescent Capital BDC's dividend payout ratio (DPR) is 84.42%.

Analysts Set New Price Targets

CCAP has been the topic of several research analyst reports. Wells Fargo & Company cut their price target on Crescent Capital BDC from $19.00 to $18.00 and set an "equal weight" rating on the stock in a research report on Friday, February 21st. Keefe, Bruyette & Woods dropped their price objective on shares of Crescent Capital BDC from $20.00 to $18.50 and set an "outperform" rating on the stock in a research note on Tuesday, April 8th. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $18.90.

Crescent Capital BDC Company Profile

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.